TFSA Investors: $10,000 in These 2 Stocks Could Help You Buy a House

TFSA investors could bet on hyper-growth tech stocks to quickly multiply their wealth. Keep an eye on stocks such as Dye & Durham (TSX:DND).

| More on:
edit Back view of hugging couple standing with real estate agent in front of house for sale

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The Tax-Free Savings Account (TFSA) really shines when you have immense capital gains. Since all capital gains in the account are tax insulated, I believe younger investors with an appetite for risk should use the opportunity to bet on some hyper-growth stocks. 

Stocks that can turn $10,000 into $100,000 in relatively little time could help you place a downpayment on a house! Plenty of famous tech stocks have delivered this 10-fold gain in recent years. Here are some smaller, lesser-known ones that could potentially do the same. 

Grow your TFSA

Stocks that can deliver 10-fold returns usually have a few things in common. For one, they’re usually innovative tech companies trying to disrupt massive industries. Andlauer Healthcare Group (TSX:AND), for example, is trying to disrupt the most obscure market niche: medicine logistics. 

The company provides supply chain management software focused on third-party logistics and delivery solutions for the healthcare sector. In other words, it makes it easier for medical institutions to purchase, track, and manage medical inventory. 

It’s a multi-billion-dollar industry that is growing an annualized pace of 7.9%. Andlauer stock has already doubled since its initial public offering. Now, my Fool colleague Ambrose O’Callaghan believes the stock could deliver a 10-fold return in just a few years. 

Legal returns

Another software stock with 10-fold potential for your TFSA is Dye & Durham (TSX:DND). Like Andlauer, D&D is focused on a niche that is crying out for disruption: law firm operations. 

D&D’s software solutions have already been adopted by the 20 largest legal firms in the country. In fact, the company recently reported 25,000 total client accounts and an average contract deal for 16.6 years. In other words, the software solutions are essential enough for companies to adopt them for several years. 

Surprisingly, the high-margin and sticky nature of the business model isn’t reflected in the stock price. D&D’s stock currently trades at just 1.7 times annual sales. That’s remarkably low for any tech firm in this environment. That could make it the perfect fit for your TFSA.

Caveats

While betting on small, hyper-growth tech stocks in your TFSA could deliver stunning returns, it could also work the other way. Losses in your TFSA are magnified by the fact that your tax-free shield is permanently compressed by the amount of your loss. 

Since your annual TFSA contribution limits are fixed, the only way for you to recover from a loss in a risky tech stock is to bet on another robust growth stock. That’s a tricky strategy that doesn’t always work out as planned. This is why I recommend devoting just a small amount (up to $10,000) of your total TFSA to any speculative tech bet. 

Foolish takeaway

TFSA investors could bet on hyper-growth tech stocks to quickly multiply their wealth. Several tech stocks have delivered 10-fold gains in recent years. That means a $10,000 investment in the right stock could turn into a sizable downpayment on a house within a few years. 

I’m watching emerging tech challengers like Dye & Durham and Andlauer Healthcare Group for such potential.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Andlauer Healthcare Group Inc.

More on Tech Stocks

A worker uses a double monitor computer screen in an office.
Tech Stocks

Why Shopify Stock Sold Off Last Week

Shopify (TSX:SHOP) sold off heavily last week. A bad earnings release may have been the culprit.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Phenomenal Growth Stocks Down 30-60% That Could Rally in the Next Bull Market

Is it time to buy growth stocks? The worst of the interest rate hike and inflation is over, and now…

Read more »

stock market
Tech Stocks

2 Best Tech Stocks to Buy Before the Next Bull Market

Tech stocks such as Roku and Nuvei can help long-term investors generate outsized gains in 2023 and beyond.

Read more »

Wireless technology
Tech Stocks

Tucows Stock Trades Near its 6-Year Low: Is it a Buy?  

Tucows stock fell 63% in the tech stock sell-off and has failed to show any recovery. Is this domain and…

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Converge Stock a Buy?

A relatively new tech stock could soar higher with the pause in rate hikes, although a resumption of the cycle…

Read more »

online shopping
Tech Stocks

Up by 25%: Is Shopify Stock Finally a Buy in 2023?

The strong rebound in the TSX’s top tech stock remains uncertain. Investors will have to wait before it delivers stellar…

Read more »

Businessman holding AI cloud
Tech Stocks

2 TSX Tech Stocks Innovating Hard in AI

Shopify (TSX:SHOP) stock and another intriguing Canadian gem make good use of AI technologies.

Read more »

worry concern
Tech Stocks

Shopify Stock: Incredible Bargain or Deceptive Trap?

Shopify has quickly shifted from a market darling to something else. Is it a safe buy or risqué bet?

Read more »